• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

壳聚糖纳米粒子的各种分子量和浓度对 RH 株速殖子的抗活性。

Anti- activity of various molecular weights and concentrations of chitosan nanoparticles on tachyzoites of RH strain.

机构信息

Department of Medical Parasitology and Mycology, Tehran University of Medical Sciences, Tehran, Iran.

Students Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

Int J Nanomedicine. 2018 Mar 8;13:1341-1351. doi: 10.2147/IJN.S158736. eCollection 2018.

DOI:10.2147/IJN.S158736
PMID:29563791
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5849388/
Abstract

BACKGROUND

Natural polysaccharides such as chitosan (CS) are widely used as antimicrobial agents. In recent years, and considering that CS has a strong antimicrobial potential, interest has been focused on antimicrobial activity of chitosan nanoparticles (CS NPs). The main factors affecting the antibacterial activity of chitosan include molecular weight (MW) and concentration. In this regard, the aim of this study was to produce various MWs and concentrations of CS NPs, through the ionic gelation method, and investigate their potential anti-parasitic activity against tachyzoites of RH strain.

MATERIALS AND METHODS

The MWs and degree of deacetylation of the CS were characterized using viscometric and acid-base titration methods, respectively. The efficacy of various MWs and concentrations of NPs was assessed by performing in vitro experiments for tachyzoites of RH strain, such as MTT assay, scanning electron microscopy, bioassay in mice and PCR. In vivo experiment was carried out in BALB/c mice which were inoculated with tachyzoites of RH strain and treated with various MWs of CS NPs.

RESULTS

The results of in vitro and in vivo experiments revealed that anti- activity strengthened as the CS NPs concentration increased and the MW decreased. In vitro experiment showed 100% mortality of tachyzoites at 500 and 1,000 ppm concentrations of low molecular weight (LMW) CS NPs after 180 min and at 2,000 ppm after 120 min. Furthermore, a 100% mortality of tachyzoites was observed at 1,000 and 2,000 ppm concentrations of medium molecular weight (MMW) CS NPs and at 2,000 ppm concentration of high molecular weight (HMW) CS NPs after 180 min. Growth inhibition rates of tachyzoites in peritoneal exudates of mice receiving low, medium and high MWs of CS NPs were found to be 86%, 84% and 79% respectively, compared to those of mice in sulfadiazine treatment group (positive control).

CONCLUSION

Various MWs of CS NPs exhibited great anti- efficiency against tachyzoites of RH strain, with the greatest efficacy shown by LMW CS NPs in both experiments. It seems that CS NPs can be used as an alternative natural medicine in the treatment of toxoplasmosis.

摘要

背景

天然多糖如壳聚糖(CS)被广泛用作抗菌剂。近年来,鉴于 CS 具有很强的抗菌潜力,人们对壳聚糖纳米粒子(CS NPs)的抗菌活性产生了兴趣。影响壳聚糖抗菌活性的主要因素包括分子量(MW)和浓度。在这方面,本研究的目的是通过离子凝胶法制备不同 MW 和浓度的 CS NPs,并研究其对 RH 株速殖子的潜在抗寄生虫活性。

材料和方法

使用粘度计和酸碱滴定法分别对 CS 的 MW 和脱乙酰度进行了表征。通过对 RH 株速殖子进行体外实验,如 MTT 测定、扫描电子显微镜、小鼠生物测定和 PCR 等,评估了不同 MW 和浓度的 NPs 的疗效。在 BALB/c 小鼠中进行了体内实验,这些小鼠接种了 RH 株速殖子,并接受了不同 MW 的 CS NPs 治疗。

结果

体内外实验结果表明,随着 CS NPs 浓度的增加和 MW 的降低,抗活性增强。体外实验结果表明,低分子量(LMW)CS NPs 在 500 和 1000 ppm 浓度下,180 分钟后速殖子的死亡率达到 100%,2000 ppm 浓度下 120 分钟后死亡率达到 100%。此外,中分子量(MMW)CS NPs 在 1000 和 2000 ppm 浓度下,HMW CS NPs 在 2000 ppm 浓度下,180 分钟后速殖子的死亡率均达到 100%。与磺胺嘧啶治疗组(阳性对照)相比,接受低、中、高 MW CS NPs 的小鼠腹腔渗出液中速殖子的生长抑制率分别为 86%、84%和 79%。

结论

不同 MW 的 CS NPs 对 RH 株速殖子表现出很强的抗效率,在两项实验中,LMW CS NPs 的效果最佳。CS NPs 似乎可以作为治疗弓形虫病的替代天然药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6034/5849388/b41223bac0fe/ijn-13-1341Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6034/5849388/2602e27d37b4/ijn-13-1341Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6034/5849388/b5819ebcf41d/ijn-13-1341Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6034/5849388/1859183d1233/ijn-13-1341Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6034/5849388/b41223bac0fe/ijn-13-1341Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6034/5849388/2602e27d37b4/ijn-13-1341Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6034/5849388/b5819ebcf41d/ijn-13-1341Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6034/5849388/1859183d1233/ijn-13-1341Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6034/5849388/b41223bac0fe/ijn-13-1341Fig4.jpg

相似文献

1
Anti- activity of various molecular weights and concentrations of chitosan nanoparticles on tachyzoites of RH strain.壳聚糖纳米粒子的各种分子量和浓度对 RH 株速殖子的抗活性。
Int J Nanomedicine. 2018 Mar 8;13:1341-1351. doi: 10.2147/IJN.S158736. eCollection 2018.
2
Successful treatment of acute experimental toxoplasmosis by spiramycin-loaded chitosan nanoparticles.载有螺旋霉素的壳聚糖纳米颗粒成功治疗急性实验性弓形虫病。
Exp Parasitol. 2019 Sep;204:107717. doi: 10.1016/j.exppara.2019.107717. Epub 2019 Jun 20.
3
The powerful synergistic effect of spiramycin/propolis loaded chitosan/alginate nanoparticles on acute murine toxoplasmosis.螺旋霉素/蜂胶载壳聚糖/海藻酸钠纳米粒对急性鼠弓形虫病的协同增效作用。
PLoS Negl Trop Dis. 2022 Mar 16;16(3):e0010268. doi: 10.1371/journal.pntd.0010268. eCollection 2022 Mar.
4
Promising Anti- Effects of Commercial Chitosan.商业壳聚糖的显著抗效。
Infect Disord Drug Targets. 2021;21(1):151-155. doi: 10.2174/1871526520666200511004932.
5
Pravastatin and Simvastatin Pretreatment in Combination with Pyrimethamine and Sulfadiazine Reduces Infection Process of Toxoplasma gondii Tachyzoites (RH Strain) in HeLa Cells.普伐他汀和辛伐他汀预处理联合乙胺嘧啶和磺胺嘧啶可降低刚地弓形虫速殖子(RH株)在HeLa细胞中的感染进程。
Acta Parasitol. 2019 Sep;64(3):612-616. doi: 10.2478/s11686-019-00076-2. Epub 2019 Jul 8.
6
Curcumin nanoemulsion as a novel chemical for the treatment of acute and chronic toxoplasmosis in mice.姜黄素纳米乳剂作为一种新型化学药物治疗小鼠急、慢性弓形虫病。
Int J Nanomedicine. 2018 Nov 9;13:7363-7374. doi: 10.2147/IJN.S181896. eCollection 2018.
7
Evaluation of the efficacy of Chitosan nanoparticles based on Rosuvastatin in the treatment of acute toxoplasmosis: An In vitro and In vivo study.基于瑞舒伐他汀的壳聚糖纳米粒治疗急性弓形虫病的疗效评价:一项体外与体内研究。
Microb Pathog. 2024 Oct;195:106897. doi: 10.1016/j.micpath.2024.106897. Epub 2024 Aug 28.
8
Chitosan and silver nanoparticles: promising anti-toxoplasma agents.壳聚糖与银纳米颗粒:颇具前景的抗弓形虫剂。
Exp Parasitol. 2014 Aug;143:30-8. doi: 10.1016/j.exppara.2014.05.005. Epub 2014 May 19.
9
Novel naltrexone hydrochloride nanovaccine based on chitosan nanoparticles promotes induction of Th1 and Th17 immune responses resulting in protection against Toxoplasma gondii tachyzoites in a mouse model.新型盐酸纳曲酮壳聚糖纳米疫苗可促进 Th1 和 Th17 免疫应答,从而在小鼠模型中预防刚地弓形虫速殖子感染。
Int J Biol Macromol. 2022 May 31;208:962-972. doi: 10.1016/j.ijbiomac.2022.03.146. Epub 2022 Mar 26.
10
Zinc oxide nanoparticles produced by Zingiber officinale ameliorates acute toxoplasmosis-induced pathological and biochemical alterations and reduced parasite burden in mice model.生姜产生的氧化锌纳米颗粒可改善急性弓形虫病引起的病理和生化改变,并降低小鼠模型中的寄生虫负担。
PLoS Negl Trop Dis. 2023 Jul 6;17(7):e0011447. doi: 10.1371/journal.pntd.0011447. eCollection 2023 Jul.

引用本文的文献

1
Killer Peptide-Containing Polyelectrolytic Nanocomplexes to Fight Infection.含杀伤肽的聚电解质纳米复合物用于抗感染
Pharmaceutics. 2025 Aug 20;17(8):1075. doi: 10.3390/pharmaceutics17081075.
2
Evaluating The Therapeutic Effect of 2-Nitroimidazole on : An In vitro and In vivo Study Using BALB/c Mice.评估2-硝基咪唑的治疗效果:一项使用BALB/c小鼠的体外和体内研究
Iran J Pharm Res. 2025 Feb 24;24(1):e157086. doi: 10.5812/ijpr-157086. eCollection 2025 Jan-Dec.
3
Study of anti-Toxoplasma gondii effect of mPEG-PCL copolymeric loaded with pyrimethamine, in vitro.

本文引用的文献

1
Triclosan resistance reversion by encapsulation in chitosan-coated-nanocapsule containing α-bisabolol as core: development of wound dressing.通过将含有α-红没药醇作为核心的壳聚糖包被纳米胶囊进行封装来逆转三氯生耐药性:伤口敷料的研发
Int J Nanomedicine. 2017 Oct 25;12:7855-7868. doi: 10.2147/IJN.S143324. eCollection 2017.
2
Inorganic and metal nanoparticles and their antimicrobial activity in food packaging applications.无机和金属纳米粒子及其在食品包装应用中的抗菌活性。
Crit Rev Microbiol. 2018 Mar;44(2):161-181. doi: 10.1080/1040841X.2017.1332001. Epub 2017 Jun 3.
3
Recent developments in antibacterial and antifungal chitosan and its derivatives.
体外研究载有乙胺嘧啶的甲氧基聚乙二醇-聚己内酯共聚物对弓形虫的抗虫效果。
AMB Express. 2025 May 2;15(1):69. doi: 10.1186/s13568-025-01876-8.
4
High Prophylactic Efficacy of Thymol Loaded Chitosan Nanoparticles for Controlling Acute Toxoplasmosis in Mice.负载百里酚的壳聚糖纳米颗粒对控制小鼠急性弓形虫病具有高度预防效果。
Iran J Parasitol. 2025 Jan-Mar;20(1):100-110. doi: 10.18502/ijpa.v20i1.18110.
5
Microfluidic-Synthesized Chitosan Nanoparticles Loaded with Azithromycin: Impact on Tissue Cysts in Mouse Model.载有阿奇霉素的微流控合成壳聚糖纳米颗粒:对小鼠模型中组织囊肿的影响
Iran J Parasitol. 2025 Jan-Mar;20(1):54-64. doi: 10.18502/ijpa.v20i1.18105.
6
Piperine-loaded mesoporous silica nanoparticles as a promising strategy for targeting Echinococcus granulosus protoscoleces.载胡椒碱的介孔二氧化硅纳米颗粒作为靶向细粒棘球绦虫原头蚴的一种有前景的策略。
Sci Rep. 2025 Jan 2;15(1):520. doi: 10.1038/s41598-024-84131-7.
7
In vitro anti- effects and apoptotic induction of queen bee acid (10-hydroxy-2-decenoic acid) alone and in combination with atovaquone.单独使用和与阿托伐醌联合使用蜂王酸(10-羟基-2-癸烯酸)的体外抗疟效果和诱导凋亡作用。
Arch Razi Inst. 2024 Apr 30;79(2):321-326. doi: 10.32592/ARI.2024.79.2.321. eCollection 2024 Apr.
8
Cytotoxic and Immunomodulatory Activity of Curcumin and Chitosan on Experimental Toxoplasmosis.姜黄素和壳聚糖对实验性弓形虫病的细胞毒性和免疫调节活性
Iran J Parasitol. 2024 Apr-Jun;19(2):224-237. doi: 10.18502/ijpa.v19i2.15858.
9
In vitro and in vivo anti-parasitic activity of curcumin nanoemulsion on Leishmania major (MRHO/IR/75/ER).姜黄素纳米乳剂对大沙鼠利什曼原虫(MRHO/IR/75/ER)的体内外抗寄生虫活性。
BMC Complement Med Ther. 2024 Jun 18;24(1):238. doi: 10.1186/s12906-024-04522-1.
10
Nano Encapsulation of An Essential Oil Transpire the Therapeutic Approach.一种精油的纳米封装传递了治疗方法。
Curr Pharm Biotechnol. 2024 May 10. doi: 10.2174/0113892010291682240423095306.
壳聚糖及其衍生物在抗菌和抗真菌方面的最新进展。
Carbohydr Polym. 2017 May 15;164:268-283. doi: 10.1016/j.carbpol.2017.02.001. Epub 2017 Feb 2.
4
Antimalarial efficacy of low molecular weight chitosan against infection in mice.低分子量壳聚糖对小鼠感染的抗疟疗效。
J Vector Borne Dis. 2016 Oct-Dec;53(4):312-316.
5
The anti-giardial effectiveness of fungal and commercial chitosan against Giardia intestinalis cysts in vitro.真菌壳聚糖和商业壳聚糖对体外肠贾第鞭毛虫囊肿的抗贾第虫有效性。
J Parasit Dis. 2016 Mar;40(1):75-80. doi: 10.1007/s12639-014-0449-z. Epub 2014 Mar 12.
6
Evaluation of different factors affecting antimicrobial properties of chitosan.壳聚糖抗菌性能的不同影响因素评估。
Int J Biol Macromol. 2016 Apr;85:467-75. doi: 10.1016/j.ijbiomac.2016.01.022. Epub 2016 Jan 11.
7
Nanobiotechnology and its applications in drug delivery system: a review.纳米生物技术及其在药物递送系统中的应用:综述
IET Nanobiotechnol. 2015 Dec;9(6):396-400. doi: 10.1049/iet-nbt.2014.0062.
8
Seroprevalence of Toxoplasma gondii Infections in Pregnant Women in Gorgan City, Golestan Province, Northern Iran-2012.2012年伊朗北部戈勒斯坦省戈尔甘市孕妇弓形虫感染血清阳性率
Iran J Parasitol. 2014 Apr-Jun;9(2):181-7.
9
Frequency of Toxoplasma gondii in HIV Positive Patients from West of Iran by ELISA and PCR.伊朗西部HIV阳性患者弓形虫感染率的ELISA和PCR检测
Iran J Parasitol. 2014 Oct-Dec;9(4):474-81.
10
1,4-Disubstituted thiosemicarbazide derivatives are potent inhibitors of Toxoplasma gondii proliferation.1,4-二取代硫代氨基脲衍生物是弓形虫增殖的有效抑制剂。
Molecules. 2014 Jul 9;19(7):9926-43. doi: 10.3390/molecules19079926.